Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Moderna Inc banner

Moderna Inc
NASDAQ:MRNA

Watchlist Manager
Moderna Inc Logo
Moderna Inc
NASDAQ:MRNA
Watchlist
Price: 147.1199 USD 7.69% Market Closed
Market Cap: $58.4B
Write Note Create Alert Ask AI

Wall St Price Targets

MRNA Price Targets Summary
Moderna Inc

Wall Street analysts forecast MRNA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRNA is 124.95 USD with a low forecast of 40.4 USD and a high forecast of 178.5 USD.

MRNA Lowest Forecast
Wall Street Target
$40.4
-73% Downside
MRNA Average Forecast
Wall Street Target
$124.95
-15% Downside
MRNA Highest Forecast
Wall Street Target
$178.5
21% Upside
Lowest Forecast
Price Target
40.4 USD
73% Downside
Average Forecast
Price Target
124.95 USD
15% Downside
Highest Forecast
Price Target
178.5 USD
21% Upside
Moderna Inc Competitors:
Price Targets

Revenue
Forecast

32% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
32% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

Over the last 8 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 8 years is 19%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
23%
Average Beat
N/A
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
23%
Average Beat

The compound annual growth rate for Gross Profit over the next 8 years is 20%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

What are analyst estimates?

Continue MRNA Research

Summary
MRNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRNA stock valuation using valuation multiples.
Wall St Estimates
MRNA price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Moderna Inc listings:
F • EUR
0QF
 SWB • EUR
0QF
 XETRA • EUR
0QF
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MRNA's stock price target?
Price Target
124.95 USD

According to Wall Street analysts, the average 1-year price target for MRNA is 124.95 USD with a low forecast of 40.4 USD and a high forecast of 178.5 USD.

What is the Revenue forecast for Moderna Inc?
Projected CAGR
19%

Over the last 8 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 8 years is 19%.

What is the Gross Profit forecast for Moderna Inc?
Projected CAGR
20%

The compound annual growth rate for Gross Profit over the next 8 years is 20%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett